India Xerostomia Therapeutics Market Analysis

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE INDIA XEROSTOMIA THERAPEUTICS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 STAGES LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET END USER COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL'S MODEL

4.2 PORTER'S 5 FORCES

4.3 GROWTH STRATEGIES ADOPTED BY THE KEY MARKET PLAYERS

5 EPIDEMIOLOGY

6 PIPELINE ANALYSIS

7 INDIA XEROSTOMIA THERAPEUTICS MARKET, REGULATIONS

8 MARKET OVERVIEW

8.1 DRIVERS

8.1.1 RISING USE OF CHEMOTHERAPY AND RADIOTHERAPY IN THE CANCER TREATMENT

8.1.2 GROWING PREVALENCE OF XEROSTOMIA

8.1.3 ADVANCEMENTS IN THE PHARMACEUTICAL RESEARCH AND DEVELOPMENT

8.1.4 INCREASING USAGE OF PRESCRIPTION MEDICINES

8.2 RESTRAINTS

8.2.1 HIGH COST ASSOCIATED WITH XEROSTOMIA TREATMENT

8.2.2 SIDE EFFECTS ASSOCIATED WITH XEROSTOMIA THERAPIES

8.3 OPPORTUNITIES

8.3.1 RISING PRODUCT COLLABORATIONS AND PARTNERSHIPS

8.3.2 RISING RESEARCH AND DEVELOPMENT ACTIVITIES FOR THE DEVELOPMENT OF NOVEL THERAPIES

8.4 CHALLENGES

8.4.1 LACK OF AWARENESS OF XEROSTOMIA

8.4.2 LACK OF TREATMENTS AVAILABLE FOR XEROSTOMIA

9 INDIA XEROSTOMIA THERAPEUTICS MARKET, BY PRODUCT TYPE

9.1 OVERVIEW

9.2 SALIVA SUBSTITUTES

9.2.1 MOUTHWASH

9.2.2 TOOTHPASTE

9.2.3 DENTIFRICES

9.2.4 ARTIFICIAL SALIVA

9.2.4.1 ORAL SOLUTION

9.2.4.1.1 ORAL SPRAY

9.2.4.1.2 ORAL RINSE

9.2.4.1.3 OTHERS

9.2.4.2 GEL

9.2.4.3 LOZENGE

9.2.4.4 DISSOLVING TABLETS

9.2.4.5 SWABS

9.2.4.6 POWDER

9.2.4.7 AQUORAL

9.2.4.8 SALIVASURE

9.2.4.9 OASIS

9.2.4.10 CAPHOSOL

9.2.4.11 XYLIMELTS

9.2.4.12 OTHERS

9.2.5 OIL-BASED SALIVA SUBSTITUTES

9.2.6 SALIVARY STIMULANTS

9.2.7 CHEWING GUMS

9.3 DRUGS

9.3.1 CHOLINOMIMETIC DRUGS

9.3.1.1 PILOCARPINE

9.3.1.2 CEVIMELINE

9.3.1.3 ANETHOLETRITHIONE

9.3.2 YOHIMBINE

9.3.3 OTHERS

9.3.4 BRANDED

9.3.5 SIALOR

9.3.6 PILOCARPINE

9.3.7 SALAGEN

9.3.8 EXOVAC

9.3.9 OTHERS

9.3.10 GENERIC

9.4 SALIVARY PEN

9.5 OTHER

10 INDIA XEROSTOMIA THERAPEUTICS MARKET, BY TYPE

10.1 OVERVIEW

10.2 TRUE XEROSTOMIA

10.3 PSEUDO XEROSTOMIA OR SYMPTOMATIC XEROSTOMIA

11 INDIA XEROSTOMIA THERAPEUTICS MARKET, BY MODE OF PURCHASE

11.1 OVERVIEW

11.2 PRESCRIPTION (RX)

11.3 OVER THE COUNTER (OTC)

12 INDIA XEROSTOMIA THERAPEUTICS MARKET, BY POPULATION TYPE

12.1 OVERVIEW

12.2 GERIATRIC

12.3 ADULTS

13 INDIA XEROSTOMIA THERAPEUTICS MARKET, BY END USER

13.1 OVERVIEW

13.2 DENTAL CLINICS

13.3 HOSPITALS

13.4 SPECIALTY CLINICS

13.5 HOME CARE

14 INDIA XEROSTOMIA THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL

14.1 OVERVIEW

14.2 RETAIL PHARMACIES

14.3 HOSPITAL PHARMACIES

14.4 ONLINE SALES

15 INDIA XEROSTOMIA THERAPEUTICS MARKET: COMPANY LANDSCAPE

15.1 COMPANY SHARE ANALYSIS: INDIA

16 SWOT ANALYSIS

17 COMPANY PROFILE

17.1 COLGATE-PALMOLIVE COMPANY.

17.1.1 COMPANY SNAPSHOT

17.1.2 REVENUE ANALYSIS

17.1.3 PRODUCT PORTFOLIO

17.1.4 RECENT DEVELOPMENTS

17.2 SUN PHARMACEUTICAL INDUSTRIES LTD.

17.2.1 COMPANY SNAPSHOT

17.2.2 REVENUE ANALYSIS

17.2.3 PRODUCT PORTFOLIO

17.2.4 RECENT DEVELOPMENTS

17.3 HALEON GROUP OF COMPANIES.

17.3.1 COMPANY SNAPSHOT

17.3.2 REVENUE ANALYSIS

17.3.3 PRODUCT PORTFOLIO

17.3.4 RECENT DEVELOPMENTS

17.4 3M

17.4.1 COMPANY SNAPSHOT

17.4.2 REVENUE ANALYSIS

17.4.3 PRODUCT PORTFOLIO

17.4.4 RECENT DEVELOPMENTS

17.5 ALISH LIFE SAVING IMPEX PRIVATE LIMITED.

17.5.1 COMPANY SNAPSHOT

17.5.2 PRODUCT PORTFOLIO

17.5.3 RECENT DEVELOPMENT

17.6 GC CORPORATION.

17.6.1 COMPANY SNAPSHOT

17.6.2 PRODUCT PORTFOLIO

17.6.3 RECENT DEVELOPMENT

17.7 ICPA HEALTH PRODUCTS LTD

17.7.1 COMPANY SNAPSHOT

17.7.2 PRODUCT PORTFOLIO

17.7.3 RECENT DEVELOPMENT

17.8 SALIWELL LTD.

17.8.1 COMPANY SNAPSHOT

17.8.2 PRODUCT PORTFOLIO

17.8.3 RECENT DEVELOPMENT

18 QUESTIONNAIRE

19 RELATED REPORTS